Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-5,209
Closed -$278K – 1137
2022
Q3
$278K Buy
5,209
+804
+18% +$50.4K 0.01% 827
2022
Q2
$253K Buy
4,405
+199
+5% +$16.1K 0.01% 892
2022
Q1
$450K Buy
4,206
+901
+27% +$103K 0.01% 678
2021
Q4
$503K Sell
3,305
-410
-11% -$93.5K 0.02% 642
2021
Q3
$956K Buy
3,715
+220
+6% +$63.4K 0.03% 411
2021
Q2
$977K Buy
3,495
+413
+13% +$92.3K 0.03% 408
2021
Q1
$624K Sell
3,082
-80
-3% -$18.6K 0.02% 508
2020
Q4
$703K Sell
3,162
-552
-15% -$124K 0.03% 436
2020
Q3
$799K Buy
3,714
+785
+27% +$163K 0.03% 367
2020
Q2
$504K Buy
+2,929
New +$369K 0.02% 464

Other funds holding DOCU

Raymond James Trust's DOCU Position: Q4 2022 in Review

Raymond James Trust sold out of DocuSign (DOCU) in Q4 2022, closing a stake of 5,209 shares — an estimated $278K sold.

Raymond James Trust first reported a position in DOCU in Q2 2020 and held it in 10 quarters. The position peaked at $977K in Q2 2021. 734 funds tracked by Wall St. Rank hold DOCU as of Q4 2022.

  • Raymond James Trust reported no remaining DocuSign position as of Q4 2022 after selling out during the quarter.
  • Raymond James Trust sold 5,209 DocuSign shares in Q4 2022, an estimated $278K.
  • Raymond James Trust first reported a position in DocuSign in Q2 2020 and held it in 10 quarters.
  • Raymond James Trust's DocuSign position peaked at $977K in Q2 2021.
  • 734 funds tracked by Wall St. Rank held DocuSign as of Q4 2022.

Based on Raymond James Trust's 13F filing for Q4 2022, filed 2 Feb 2023.